van Asperen CJ - Search Results

1

Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programs.

Vreeswijk MP, Kraan JN, van der Klift HM, Vink GR, Cornelisse CJ, Wijnen JT, Bakker E, van Asperen CJ, Devilee P. Vreeswijk MP, et al. Among authors: van asperen cj, van der klift hm. Hum Mutat. 2009 Jan;30(1):107-14. doi: 10.1002/humu.20811. Hum Mutat. 2009. PMID: 18693280

2

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: van asperen cj. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

3

Risk estimation for healthy women from breast cancer families: new insights and new strategies.

van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH. van Asperen CJ, et al. Among authors: van diemen homan je, van houwelingen jc. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):87-93. doi: 10.1158/1055-9965.epi-03-0090. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744738

4

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.

van Dijk S, van Asperen CJ, Jacobi CE, Vink GR, Tibben A, Breuning MH, Otten W. van Dijk S, et al. Among authors: van asperen cj. Genet Test. 2004 Fall;8(3):235-9. doi: 10.1089/gte.2004.8.235. Genet Test. 2004. PMID: 15727245

5

Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines.

Vink GR, van Asperen CJ, Devilee P, Breuning MH, Bakker E. Vink GR, et al. Among authors: van asperen cj. Eur J Hum Genet. 2005 May;13(5):525-7. doi: 10.1038/sj.ejhg.5201379. Eur J Hum Genet. 2005. PMID: 15741995 No abstract available.

6

Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.

van Puijenbroek M, van Asperen CJ, van Mil A, Devilee P, van Wezel T, Morreau H. van Puijenbroek M, et al. Among authors: van asperen cj, van mil a, van wezel t. J Pathol. 2005 Jun;206(2):198-204. doi: 10.1002/path.1764. J Pathol. 2005. PMID: 15818573

7

A genome wide linkage search for breast cancer susceptibility genes.

Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G; kConFab Investigators; Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, McCredie MR, Buys S, Andrulis I, Senie R; BCFS, BRCAX Collaborators Group; Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JG, van Asperen C, van Leeuwen I, Vasen HF, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal P, Nathanson KL, Weber BL; Breast Cancer Susceptibility Collaboration (UK); Rahman N, Stratton MR. Smith P, et al. Among authors: van leeuwen i, van asperen c. Genes Chromosomes Cancer. 2006 Jul;45(7):646-55. doi: 10.1002/gcc.20330. Genes Chromosomes Cancer. 2006. PMID: 16575876 Free PMC article.

8

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.

Jacobi CE, van Ierland Y, van Asperen CJ, Hallensleben E, Devilee P, Jan Fleuren G, Kenter GG. Jacobi CE, et al. Among authors: van asperen cj, van ierland y. Genet Med. 2007 Mar;9(3):173-9. doi: 10.1097/GIM.0b013e318032e4ab. Genet Med. 2007. PMID: 17413421 Free article. Clinical Trial.

9

Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.

Gonzalez-Neira A, Rosa-Rosa JM, Osorio A, Gonzalez E, Southey M, Sinilnikova O, Lynch H, Oldenburg RA, van Asperen CJ, Hoogerbrugge N, Pita G, Devilee P, Goldgar D, Benitez J. Gonzalez-Neira A, et al. Among authors: van asperen cj. BMC Genomics. 2007 Aug 30;8:299. doi: 10.1186/1471-2164-8-299. BMC Genomics. 2007. PMID: 17760956 Free PMC article.

10

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.

Huijts PE, Vreeswijk MP, Kroeze-Jansema KH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Wijers-Koster PM, Blom JC, Pooley KA, Klijn JG, Tollenaar RA, Devilee P, van Asperen CJ. Huijts PE, et al. Among authors: van asperen cj. Breast Cancer Res. 2007;9(6):R78. doi: 10.1186/bcr1793. Breast Cancer Res. 2007. PMID: 17997823 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters